Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2008
12/03/2008EP1996559A1 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
12/03/2008EP1996551A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them.
12/03/2008EP1996230A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies
12/03/2008EP1996200A1 Use of adenine-derived compounds for the treatment of lupus
12/03/2008EP1996179A2 Compositions for disorders associated with metachromatic cell activation
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008EP1511499B1 Immunomodulatory compounds and methods of use thereof
12/03/2008EP1373218B9 Imidazolyl derivatives useful as histamine h3 receptor ligands
12/03/2008EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
12/03/2008EP1303293B1 Sequential administration of cpt-11 and apo-2l polypeptide
12/03/2008EP1079804B1 Pharmaceutical compositions comprising an amphoteric surfactant an polypropoxylated cetyl alcohol and a polar drug
12/03/2008EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors
12/03/2008EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof
12/03/2008CN101316930A T-cell adhesion molecule and antibody directed against the molecule
12/03/2008CN101314615A Viral capsid mosaic protein HPV16 L1-P<D>, preparation method and application thereof
12/03/2008CN101314033A Oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof
12/03/2008CN101314026A Serositis in duckling vaccine oral liquid synergistic agent for poultry biology and preparation method thereof
12/03/2008CN101314008A Farina effervescent tablet
12/03/2008CN101313978A Bacillus coli vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof
12/03/2008CN101313977A Intestine toxicity syndrome vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof
12/03/2008CN101313976A Bursa of fabricius vaccine oral liquid synergistic agent for poultry and preparation method thereof
12/03/2008CN101313968A Pseudo-ginseng dragon's blood preparation
12/03/2008CN101313932A Compound mushroom capsule
12/03/2008CN101313924A Preparation of low sugar panax ginseng and uses thereof
12/03/2008CN101313814A Health-care bedding and its making method
12/03/2008CN101313763A Fig oral liquid and preparation method thereof
12/03/2008CN101313749A Male silk moth capsule and its preparing process
12/03/2008CN100439920C Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
12/03/2008CN100439499C Neutrokine-alpha and Neutrokine-alpha splice variant
12/03/2008CN100439400C Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
12/03/2008CN100439399C Human antibodies that bind human IL-12 and methods for producing
12/03/2008CN100439397C Crystallization of IGF-1
12/03/2008CN100439370C Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100438882C Health care oral liquid of phellinus igniarius and its preparing method
12/03/2008CN100438877C (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
12/03/2008CN100438870C Method for treating diseases with omega interferon
12/03/2008CN100438862C Composition for administration to mucosa and containing coenzyme Q as active ingredient
12/02/2008US7459544 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459538 Recombinant tumor specific antibody and use thereof
12/02/2008US7459528 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents
12/02/2008US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/02/2008US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459270 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
12/02/2008US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens
12/02/2008CA2396111C Substances for use in treating psoriasis
12/02/2008CA2394230C Novel stromelysin inhibitors
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2269780C Polyanionic polymers as adjuvants for mucosal immunization
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2241918C Peanut allergens and methods
12/02/2008CA2140220C Inhibition of infection-stimulated oral tissue destruction by .beta.(1,3)-glucan
11/2008
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008144360A1 Novel compounds as cannabinoid receptor ligands
11/27/2008WO2008143674A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/27/2008WO2008143594A1 Hypoallergenic polypeptides
11/27/2008WO2008143254A1 Pharmaceutical containing pparδ agonist
11/27/2008WO2008142513A2 Phosphate-modified oligonucleotide analogs with immunostimulatory activity
11/27/2008WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008WO2008142165A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008WO2008098749A3 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof
11/27/2008WO2008077145A3 Treatment of il-1-beta related diseases
11/27/2008WO2008032153A3 Calreticulin for its use as a medication for the treatment of cancer in a mammal
11/27/2008WO2008014219A3 Thiozolidinedione derivatives as p13 kinase inhibitors
11/27/2008WO2008011114A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/27/2008WO2007149481A3 Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
11/27/2008US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents
11/27/2008US20080293794 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
11/27/2008US20080293749 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position
11/27/2008US20080293732 Substituted pyrazoles
11/27/2008US20080293712 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/27/2008US20080293665 Purine Nucleotide Derivatives
11/27/2008US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293653 Method of treating autoimmune diseases
11/27/2008US20080293641 Biologically active peptides
11/27/2008US20080293636 Protein Constructs Designed for Targeting and Lysis of Cells
11/27/2008US20080293627 Thyrotropin Receptor Preparations, Binding Regions Thereof, Antibody and Hormone Interactions Therewith, and Uses Thereof
11/27/2008US20080292726 Ophthalmic gallium compositions and methods of their use
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292659 vaccination with a live equine influenza vaccine (prime) is followed by vaccination with an inactivated influenza vaccine (boost), wherein the two shots are given no longer than 8 weeks apart; horses
11/27/2008US20080292657 Primate t-lymphotropic viruses
11/27/2008US20080292656 Combination of a Bacterial Cell and a Biologically Active Agent
11/27/2008US20080292655 Enhancement of the immune response for vaccine and gene therapy applications
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292652 Virus-Like Particles Comprising a Fusion Protein of the Coat Protein of Ap205 and an Antigenic Polypeptide
11/27/2008US20080292648 Synthetic agonists of tlr9
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292643 Leukocyte inactivation module
11/27/2008US20080292641 Antigenic GM-CSF peptides and antibodies to GM-CSF
11/27/2008US20080292635 Allergenic latex protein
11/27/2008US20080292634 Nontypable Haemophilus Infuenzae Virulence Factors
1 ... 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 ... 1172